NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

What kind of results can you expect on Survaxm? I can tell there is only one result pending for Survaxm: Failure. What is the target Survaxm chose? Is it survivin?

If you read Dr. Liau's papers, you should know that Dr. Liau conducted a trial by loading DCs with peptides derived from antigens TRP-2, gp100, her-2/neu, and survivin. The trial results cannot outperform those from the approach which adopted tumor-lysate. Clearly, Survaxm cannot beat DCVax-L.

https://pmc.ncbi.nlm.nih.gov/articles/PMC3568250/pdf/nihms-433120.pdf

Are you guys still talking about the p3 trial? Have you seen Dr. Liau was involved in every important aspect of the p3 trial? Next time watch the following news first before talking about the p3 trial.

BTW, do you see FDA finally is getting back the commonsense? To be honest, I already have a foretaste of generational wealth in my mind.

https://med.stanford.edu/alumni/events/sterling-award.html

Concept and design: Liau, Ashkan, Ansstas, Walter, Prins, Boynton, Bosch.
Acquisition, analysis, or interpretation of data: Liau, Ashkan, Brem, Campian, Trusheim, ......
Drafting of the manuscript: Liau, Ashkan, Cobbs, Elinzano, Brenner, Kim, Nadji-Ohl, Peak,......
Critical revision of the manuscript for important intellectual content: Liau, Ashkan, Brem, Campian, Trusheim, Iwamoto, ......
Statistical analysis: Liau, Bosch.
Administrative, technical, or material support: Liau, Ashkan, Brem, Iwamoto, Tran, ......
Supervision: Liau, Ashkan, Brem, Campian, ......